Research ArticleADULT BRAIN
Open Access
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg and T. Granberg
American Journal of Neuroradiology July 2017, 38 (7) 1311-1316; DOI: https://doi.org/10.3174/ajnr.A5211
Y. Forslin
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
S. Shams
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
F. Hashim
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
P. Aspelin
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
G. Bergendal
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
cNeurology (G.B., S.F.)
J. Martola
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
S. Fredrikson
cNeurology (G.B., S.F.)
dClinical Neuroscience (S.F.), Karolinska Institutet, Stockholm, Sweden.
M. Kristoffersen-Wiberg
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
T. Granberg
aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)

References
- 1.↵
- 2.↵
- 3.↵
- Frenzel T,
- Lengsfeld P,
- Schirmer H, et al
- 4.↵
- 5.↵
- White GW,
- Gibby WA,
- Tweedle MF
- 6.↵
- Idée JM,
- Port M,
- Dencausse A, et al
- 7.↵
- 8.↵
- Kanda T,
- Ishii K,
- Kawaguchi H, et al
- 9.↵
- Errante Y,
- Cirimele V,
- Mallio CA, et al
- 10.↵
- 11.↵
- Quattrocchi CC,
- Mallio CA,
- Errante Y, et al
- 12.↵
- Kanda T,
- Fukusato T,
- Matsuda M, et al
- 13.↵
- Murata N,
- Gonzalez-Cuyar LF,
- Murata K, et al
- 14.↵
- Robert P,
- Lehericy S,
- Grand S, et al
- 15.↵
- 16.↵
- 17.↵
- Poser CM,
- Paty DW,
- Scheinberg L, et al
- 18.↵
- Reuter M,
- Schmansky NJ,
- Rosas HD, et al
- 19.↵
- 20.↵
- Kurtzke JF
- 21.↵
- Lezak MD
- 22.↵
- Benjamini Y,
- Krieger AM,
- Yekutieli D
- 23.↵
- 24.↵
- Stojanov DA,
- Aracki-Trenkic A,
- Vojinovic S, et al
- 25.↵
- 26.↵
- 27.↵
- Minagar A,
- Barnett MH,
- Benedict RH, et al
- 28.↵
- Filippi M,
- Rocca MA,
- Barkhof F, et al
- 29.↵
- 30.↵
- Ramalho J,
- Ramalho M,
- AlObaidy M, et al
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- 37.↵
In this issue
American Journal of Neuroradiology
Vol. 38, Issue 7
1 Jul 2017
Advertisement
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg
American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin, S. Shams, F. Hashim, P. Aspelin, G. Bergendal, J. Martola, S. Fredrikson, M. Kristoffersen-Wiberg, T. Granberg
American Journal of Neuroradiology Jul 2017, 38 (7) 1311-1316; DOI: 10.3174/ajnr.A5211
Jump to section
Related Articles
Cited By...
- MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis
- Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS
- Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologists Perspective
- Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
- Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent
- Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
ADULT BRAIN
PATIENT SAFETY
Similar Articles
Advertisement